Advances in the Management of Hematologic Diseases: Pipeline Drugs Become Clinical Reality
Release Date: June 23, 2009|
Expiration Date: June 23, 2010
May 30, 2009, Orlando, FL
This on-demand Webcast is from a satellite symposium held in conjunction with the 45th Annual Meeting of the American Society of Clinical Oncology held on May 29-June 2, 2009, in Orlando, FL.
The Advances in the Management of Hematologic Diseases: Pipeline Drugs Become Clinical Reality symposium has been designed to provide participants with leading-edge information on the novel, targeted anticancer therapies that are being developed for patients with hematologic malignancies, highlighting the mechanisms of action and the most current clinical data with these agents. This symposium will detail several of the key advancements in the rational targeting of proteins/processes that are disrupted in cancer and benign hematologic disorders, such as thrombopoiesis, fusion genes, and cell-cycle progression.
This educational activity is directed toward medical oncologists, translational researchers (both MDs and PhDs), drug developers from academia and industry, and other persons interested in cancer drug development. Fellows, nurses, physician assistants, and pharmacists are also invited to participate.
Upon completion of this educational activity, you should be able to:
You will be permitted 2 attempts to successfully complete the Posttest.